|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 09-16 | Vericel Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 02:35 PM | |
| 07-31 | Truist Raises Price Target on Vericel to $58 From $54, Keeps Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.48% | +1.87% | +1.36% | -2.25% | +9.10% | +53.67% | +117.82% | +407.46% | +1,360.85% | 1,056B | ||
| -0.65% | -1.10% | +0.13% | +4.82% | +28.63% | +43.57% | +71.58% | +64.83% | +125.35% | 645B | ||
| -0.09% | -0.71% | +2.64% | +4.59% | +15.19% | +13.67% | +77.54% | +144.00% | +317.31% | 465B | ||
| -2.27% | -1.08% | -0.86% | +14.00% | +39.17% | +74.53% | +42.84% | +95.03% | +134.71% | 368B | ||
| -0.06% | -3.88% | -1.05% | +4.90% | +6.37% | +34.32% | +40.74% | +2.09% | +44.85% | 335B | ||
| -0.79% | +2.01% | -2.68% | -5.23% | +9.45% | +19.82% | +28.48% | +56.14% | +57.02% | 275B | ||
| -1.19% | -1.21% | +2.66% | -12.91% | -10.95% | +9.82% | +12.15% | +37.08% | +145.40% | 255B | ||
| -0.55% | +4.10% | -1.66% | +16.74% | +29.15% | +49.80% | +58.74% | +98.79% | +153.42% | 229B | ||
| -0.79% | -0.69% | +2.72% | +18.98% | +22.47% | +35.42% | +102.86% | +115.20% | +89.99% | 188B | ||
| +0.62% | +0.38% | -13.41% | -19.52% | -22.15% | -26.53% | -60.24% | -18.51% | +83.88% | 169B | ||
| +0.09% | +2.40% | +1.39% | +19.83% | +15.88% | +13.25% | -14.98% | -32.91% | -14.81% | 164B | ||
| -0.27% | +1.84% | -3.43% | +5.86% | +15.99% | +34.27% | +51.18% | +189.90% | +502.97% | 134B | ||
| -0.08% | +2.99% | -5.73% | +9.30% | +16.76% | +39.65% | +8.87% | +6.44% | +16.80% | 128B | ||
| -0.55% | -2.28% | -2.82% | +13.87% | +4.89% | +11.37% | +96.70% | +331.54% | +415.98% | 101B | ||
| -1.29% | -2.86% | -2.11% | -7.52% | +0.41% | +16.35% | +23.45% | +4.42% | -10.80% | 98.21B | ||
| +1.64% | -0.64% | -5.43% | -3.25% | -12.19% | -7.52% | -28.66% | -12.57% | +7.39% | 97.03B | ||
| -6.88% | +5.85% | +37.35% | +175.25% | +553.65% | +646.26% | +86.58% | -49.91% | - | 81.23B | ||
| +1.17% | -5.00% | -4.67% | +22.17% | -1.31% | +35.48% | -6.88% | +25.87% | +89.48% | 74.94B | ||
| +0.51% | +3.87% | -0.65% | -5.96% | +12.64% | +26.18% | -10.61% | -26.41% | +43.99% | 67.69B | ||
| Average | -0.66% | +0.19% | +0.20% | +13.35% | +38.59% | +59.12% | +36.74% | +75.71% | +197.99% | 259.47B | |
| Weighted average by Cap. | -0.80% | +0.28% | +0.11% | +6.11% | +22.44% | +45.11% | +58.86% | +140.02% | +405.69% |
- Stock Market
- Stocks
- VCEL Stock
- Stock
- Sector Aastrom Biosciences Inc
Select your edition
All financial news and data tailored to specific country editions
















